Skip to main content

Advertisement

ADVERTISEMENT

Volume 20 - Issue 2 - February, 2008

Column

Editorial Message
08/01/2008
NULL
NULL
NULL
08/01/2008
Journal of Invasive Cardiology
Editorial Message
08/01/2008
Richard E. Shaw, Phd, FACC, FACA Editor-in-Chief
Richard E. Shaw, Phd, FACC, FACA Edit...
This issue of the Journal of Invasive Cardiology includes original research articles, a review article, selections from the journal special section Clinical Images and online case reports which can be found in the archive section on our...
This issue of the Journal of Invasive Cardiology includes original research articles, a review article, selections from the journal special section Clinical Images and online case reports which can be found in the archive section on our...
This issue of the Journal of...
08/01/2008
Journal of Invasive Cardiology

Feature

Case Report
08/01/2008
Manojkumar Rohit, MD, DM, Shivkumar Bagga, MD, DM, Kewal Krishan Talwar, MD, DM
Manojkumar Rohit, MD, DM, Shivkumar B...
The incidence of primary congenital coronary anomalies varies from 0.95–2% in the adult population undergoing coronary angiography (CAG).1–4 The majority of these are reported to be anomalies of origin or distribution, with separate ostia of...
The incidence of primary congenital coronary anomalies varies from 0.95–2% in the adult population undergoing coronary angiography (CAG).1–4 The majority of these are reported to be anomalies of origin or distribution, with separate ostia of...
The incidence of primary...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
a-eRobert L. Huang MD, MPH, dAnderson Donelli, MD, dJeannie Byrd, RN, eMarc A. Mickiewicz, MD, eCorey Slovis, MD, a-c,fChristianne Roumie, MD, MPH, a-c,fTom A. Elasy, MD, MPH, a-c,fRobert S. Dittus, MD, MPH, a-cTed Speroff, PhD, dTom DiSalvo, MD, MPH, dDavid Zhao, MD
a-eRobert L. Huang MD, MPH, dAnderson...
An estimated 500,000 patients per year in the United States1 experience a ST-elevation MI (STEMI) with a shortterm mortality rate of 5–10%.2 Percutaneous coronary intervention (PCI) is the preferred approach for treating STEMI1 and timely...
An estimated 500,000 patients per year in the United States1 experience a ST-elevation MI (STEMI) with a shortterm mortality rate of 5–10%.2 Percutaneous coronary intervention (PCI) is the preferred approach for treating STEMI1 and timely...
An estimated 500,000 patients...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Jonathan D. Marmur, MD, Shyam Poludasu, MD, Ajay Agarwal, MD, Nagarathna Manjappa MD, Erdal Cavusoglu, MD
Jonathan D. Marmur, MD, Shyam Poludas...
Inhibition of platelet glycoprotein IIb/IIIa receptors during percutaneous coronary intervention (PCI) using tirofiban, eptifibatide and abciximab has been associated with improved outcomes.1 The only head-to-head comparison to these agents...
Inhibition of platelet glycoprotein IIb/IIIa receptors during percutaneous coronary intervention (PCI) using tirofiban, eptifibatide and abciximab has been associated with improved outcomes.1 The only head-to-head comparison to these agents...
Inhibition of platelet...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Salvatore Azzarelli, MD, Francesco Amico, MD, *Alfredo R. Galassi, MD, Michele Giacoppo, MD, Vincenzo Argentino, MD, Antonio Fiscella, MD
Salvatore Azzarelli, MD, Francesco Am...
Drug-eluting stents (DES), compared with bare-metal stents (BMS), have shown a clear superiority in the prevention of restenosis and the need for further revascularization in randomized, controlled trials.1–5 Accordingly, the superiority of...
Drug-eluting stents (DES), compared with bare-metal stents (BMS), have shown a clear superiority in the prevention of restenosis and the need for further revascularization in randomized, controlled trials.1–5 Accordingly, the superiority of...
Drug-eluting stents (DES),...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Sanjay Rajdev, MD, Prakash Krishnan, MD, Adil Irani, MD, Michael C. Kim, MD, Pedro R. Moreno, MD, Samin K. Sharma, MD, Annapoorna S. Kini, MD
Sanjay Rajdev, MD, Prakash Krishnan, ...
Introduction of novel devices for cardiac support during complex percutaneous coronary intervention (PCI) has revolutionized the treatment of coronary artery disease (CAD) and has led to an increasing number of high-risk PCI procedures....
Introduction of novel devices for cardiac support during complex percutaneous coronary intervention (PCI) has revolutionized the treatment of coronary artery disease (CAD) and has led to an increasing number of high-risk PCI procedures....
Introduction of novel devices...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
David G. Rizik, MD, Kevin J. Klassen, MD, James B. Hermiller, MD
David G. Rizik, MD, Kevin J. Klassen,...
Published randomized trials of drug-eluting stents (DES) have shown reduced rates of restenosis and target lesion revascularization (TLR) in noncomplex lesions compared to bare-metal stents (BMS).1 Given this documented success of the...
Published randomized trials of drug-eluting stents (DES) have shown reduced rates of restenosis and target lesion revascularization (TLR) in noncomplex lesions compared to bare-metal stents (BMS).1 Given this documented success of the...
Published randomized trials of...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
08/01/2008
Tim A. Fischell, MD
Tim A. Fischell, MD
Platelet-mediated thromboembolic events are believed to cause the majority of non-Q-wave myocardial infarctions (MI) observed after an otherwise uncomplicated percutaneous coronary intervention (PCI).1 Activation of the platelet-surface...
Platelet-mediated thromboembolic events are believed to cause the majority of non-Q-wave myocardial infarctions (MI) observed after an otherwise uncomplicated percutaneous coronary intervention (PCI).1 Activation of the platelet-surface...
Platelet-mediated thromboembolic...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
*,§Fayaz Shawl, MD and *,£Robert J. Lederman, MD
*,§Fayaz Shawl, MD and *,£Robert J....
This series from Mount Sinai Hospital extends the reported experience with prophylactic deployment of a percutaneous transseptal cardiopulmonary bypass system during high-risk elective coronary angioplasty. These highly experienced operators...
This series from Mount Sinai Hospital extends the reported experience with prophylactic deployment of a percutaneous transseptal cardiopulmonary bypass system during high-risk elective coronary angioplasty. These highly experienced operators...
This series from Mount Sinai...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement